|
Re: Great Presetation today
|
4
|
Zenith Epigenetics
|
Oct 18, 2017 06:20AM
|
|
Re: Win or lose....one thing we know for sure
|
4
|
Resverlogix Corp.
|
Sep 02, 2019 12:25PM
|
|
Re: Gran Oso....
|
4
|
Resverlogix Corp.
|
Nov 19, 2019 08:21AM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
4
|
Resverlogix Corp.
|
Sep 23, 2018 07:58AM
|
|
Re: Patient Enrollment Modeling
|
4
|
Resverlogix Corp.
|
Dec 02, 2018 08:07AM
|
|
Re: No love
|
4
|
Resverlogix Corp.
|
Dec 13, 2018 12:46PM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
4
|
Resverlogix Corp.
|
Oct 05, 2019 11:34PM
|
|
Re: BETonMACE details
|
4
|
Resverlogix Corp.
|
May 16, 2018 11:08PM
|
|
Re: Phase 2 Kidney Trial
|
4
|
Resverlogix Corp.
|
Jan 24, 2017 05:09PM
|
|
Re: Success or Failure?
|
4
|
Resverlogix Corp.
|
Oct 05, 2019 11:43PM
|
|
Re: Revamped website
|
4
|
Resverlogix Corp.
|
Jan 06, 2019 07:35AM
|
|
Re: BetonMace Phase 111 Trial opinions...
|
4
|
Resverlogix Corp.
|
Jun 04, 2015 02:11PM
|
|
Re: My guess is a second BTD is coming
|
4
|
Resverlogix Corp.
|
Feb 08, 2020 10:36AM
|
|
Re: Safety, tolerability and efficacy for CKD and Fabry trials!
|
4
|
Resverlogix Corp.
|
Jul 16, 2018 10:33AM
|
|
Re: Just back from IR,...
|
4
|
Resverlogix Corp.
|
Oct 27, 2019 06:39PM
|
|
Re: New MD&A posted
|
4
|
Resverlogix Corp.
|
Dec 18, 2019 01:15PM
|
|
Re: Financial Times article on UCSF Covid project about the 69 potential drugs
|
4
|
Resverlogix Corp.
|
May 01, 2020 10:24PM
|
|
Re: Naz listing requirements....
|
4
|
Resverlogix Corp.
|
Sep 06, 2018 02:01PM
|
|
Re: A New Frontier in CV Risk Reduction for Patients With Type 2 Diabetes
|
4
|
Resverlogix Corp.
|
Dec 17, 2018 03:11PM
|
|
Re: BETonMACE Placebo Estimate
|
4
|
Resverlogix Corp.
|
Feb 23, 2019 11:00AM
|
